A Onasemnogene abeparvovec 1 once,Ｂ Axicabtagene ciloleucel 1 once,Ｃ Idecabtagene vicleucel 1 once,Ｄ Lisocabtagene maraleucel 1 once

⑴ Official in charge of disbursement of the procuring entity : Mikio Suzuki, Executive Director, Duly Authorized Representative to Ikue Kina, President University of the Ryukyus ⑵ Classification of the products to be procured : 4 ⑶ Nature and quantity of the products to be purchased : A Onasemnogene abeparvovec 1 once B Axicabtagene ciloleucel 1 once C Idecabtagene vicleucel 1 once D Lisocabtagene maraleucel 1 once ⑷ Delivery period : From 1 October, 2026 through 30 September, 2028 ⑸ Delivery place : University of the Ryukyus Hospital ⑹ Qualifications for participating in the tendering procedures : Suppliers eligible for participating in the proposed tender are those who shall : A not come under Article 14 of the Regulation concerning the Contract for University of the Ryukyus, B have the Grade A, Grade B or Grade C qualification during fiscal 2026 in the Kyushu・Okinawa area in sales of product for participating in tenders by Single qualification for every ministry and agency, C prove to have prepared a system to provide rapid after-sale service and maintenance for the procured products, D prove to have the ability to deliver the products, required by this notice, on the date and to the place specified by the Obligating Officer, E prove to have obtained license for selling a medical instrument in accordance with the Law on Securing Quality, Efficacy and Safety of Products including Pharmaceuticals and Medical Devices, F not be currently under a suspension of business order as instructed by President University of the Ryukyus. ⑺ Time limit of tender : 17 : 00 14 September, 2026 ⑻ Contact point for the notice : Tomohide Higa, Second Procurement Subsection, Accounting Affairs, Administration Department of Nishifutenma Campus, 1076 Aza Kiyuna Ginowan-city Okinawa 901-2725 Japan, TEL 098-894-1347 ⑼ Please be noted that if it is indicated that environmental conditions relating to the procurement are laid down in its tender documents. 0004 Medical & Pharmaceutical Product